Literature DB >> 23886508

Embryology of the heart and its impact on understanding fetal and neonatal heart disease.

Adriana C Gittenberger-de Groot1, Margot M Bartelings, Robert E Poelmann, Monique C Haak, Monique R M Jongbloed.   

Abstract

Heart development is a complex process during which the heart needs to transform from a single tube towards a fully septated heart with four chambers and a separated outflow tract. Several major events contribute to this process, that largely overlap in time. Abnormal heart development results in congenital heart disease, which has an estimated incidence of 1% of liveborn children. Eighty percent of cases of congenital heart disease are considered to have a multifactoral developmental background, whereas knowledge of monogenetic causes for congenital heart disease is still limited. This review focuses on several novel findings in cardiac development that might enhance our knowledge of aetiology and support refinement of prenatal diagnosis of congenital heart disease.
Copyright © 2013. Published by Elsevier Ltd.

Entities:  

Keywords:  Cardiac development; Congenital heart malformation; Epicardium; First heart field; Neural crest cells; Nuchal translucency; Second heart field

Mesh:

Year:  2013        PMID: 23886508     DOI: 10.1016/j.siny.2013.04.008

Source DB:  PubMed          Journal:  Semin Fetal Neonatal Med        ISSN: 1744-165X            Impact factor:   3.926


  19 in total

Review 1.  Defining the Cardiac Fibroblast.

Authors:  Malina J Ivey; Michelle D Tallquist
Journal:  Circ J       Date:  2016-10-14       Impact factor: 2.993

Review 2.  The multiple, complex roles of versican and its proteolytic turnover by ADAMTS proteases during embryogenesis.

Authors:  Sumeda Nandadasa; Simon Foulcer; Suneel S Apte
Journal:  Matrix Biol       Date:  2014-01-18       Impact factor: 11.583

Review 3.  Embryonic Chicken (Gallus gallus domesticus) as a Model of Cardiac Biology and Development.

Authors:  José G Vilches-Moure
Journal:  Comp Med       Date:  2019-06-10       Impact factor: 0.982

4.  Morphological features of complex congenital cardiovascular anomalies in fetuses: as evaluated by cast models.

Authors:  Hai-Yan Cao; Yu Wang; Liu Hong; Wei Han; Lin He; Ben-Cai Song; Yun-Fei Hu; Yuan Peng; Bin Wang; Jing Wang; Wen-Ying Huang; Jing Deng; Ming-Xing Xie
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2017-08-08

Review 5.  The Transitional Heart: From Early Embryonic and Fetal Development to Neonatal Life.

Authors:  Cheryl Mei Jun Tan; Adam James Lewandowski
Journal:  Fetal Diagn Ther       Date:  2019-09-18       Impact factor: 2.587

6.  Abnormal aortic arch morphology in Turner syndrome patients is a risk factor for hypertension.

Authors:  Katya De Groote; Daniël Devos; Koen Van Herck; Laurent Demulier; Wesley Buysse; Jean De Schepper; Daniël De Wolf
Journal:  Heart Vessels       Date:  2014-06-17       Impact factor: 2.037

7.  Foxc2 is required for proper cardiac neural crest cell migration, outflow tract septation, and ventricle expansion.

Authors:  Kimberly E Inman; Carlo Donato Caiaffa; Kristin R Melton; Lisa L Sandell; Annita Achilleos; Tsutomu Kume; Paul A Trainor
Journal:  Dev Dyn       Date:  2018-12       Impact factor: 3.780

Review 8.  The Role of Cell Tracing and Fate Mapping Experiments in Cardiac Outflow Tract Development, New Opportunities through Emerging Technologies.

Authors:  Joshua C Peterson; Tim P Kelder; Marie José T H Goumans; Monique R M Jongbloed; Marco C DeRuiter
Journal:  J Cardiovasc Dev Dis       Date:  2021-04-26

Review 9.  Tissue engineering: Relevance to neonatal congenital heart disease.

Authors:  Kevin M Blum; Gabriel J M Mirhaidari; Christopher K Breuer
Journal:  Semin Fetal Neonatal Med       Date:  2021-02-27       Impact factor: 3.726

10.  Prognosis and Risk Factors for Congenital Airway Anomalies in Children with Congenital Heart Disease: A Nationwide Population-Based Study in Taiwan.

Authors:  Yu-Sheng Lee; Mei-Jy Jeng; Pei-Chen Tsao; Wen-Jue Soong; Pesus Chou
Journal:  PLoS One       Date:  2015-09-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.